Bailard’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-6,500
| Closed | -$309K | – | 614 |
|
|
2019
Q1 | $309K | Hold |
6,500
| – | – | 0.02% | 417 |
|
|
2018
Q4 | $235K | Hold |
6,500
| – | – | 0.02% | 453 |
|
|
2018
Q3 | $400K | Hold |
6,500
| – | – | 0.02% | 422 |
|
|
2018
Q2 | $439K | Sell |
6,500
-16,150
| -71% | -$1.09M | 0.03% | 392 |
|
|
2018
Q1 | $1.23M | Hold |
22,650
| – | – | 0.08% | 202 |
|
|
2017
Q4 | $1.35M | Buy |
22,650
+5,400
| +31% | +$323K | 0.09% | 207 |
|
|
2017
Q3 | $838K | Sell |
17,250
-17,250
| -50% | -$838K | 0.06% | 179 |
|
|
2017
Q2 | $1.81M | Sell |
34,500
-16,000
| -32% | -$841K | 0.15% | 137 |
|
|
2017
Q1 | $2.29M | Sell |
50,500
-32,500
| -39% | -$1.47M | 0.19% | 117 |
|
|
2016
Q4 | $3.14M | Hold |
83,000
| – | – | 0.29% | 91 |
|
|
2016
Q3 | $3.13M | Sell |
83,000
-30,000
| -27% | -$1.13M | 0.29% | 87 |
|
|
2016
Q2 | $1.99M | Hold |
113,000
| – | – | 0.24% | 106 |
|
|
2016
Q1 | $1.37M | Buy |
113,000
+93,000
| +465% | +$1.13M | 0.19% | 83 |
|
|
2015
Q4 | $487K | Sell |
20,000
-13,000
| -39% | -$317K | 0.21% | 141 |
|
|
2015
Q3 | $585K | Buy |
+33,000
| New | +$585K | 0.09% | 128 |
|